National Law Review17h
HHS-OIG Highlights Anti-Fraud Safeguards of Drug Manufacturer’s Free Drug Program for Patients in Financial Need
Highlights The HHS-OIG released a favorable opinion regarding free drugs offered to patients in financial need for a drug ...
STAT1d
Tapping the potential of GLP-1 drugs requires integrated care and overcoming inequities, executives say
At STAT's Breakthrough Summit East, the CEOs of Ro and Included Health said the the U.S. health care system poses obstacles ...
Health Affairs1d
Fosamax Lawsuit: The Importance Of State Duties To Warn Of Drug Dangers
Fosamax further defines the obligation of drug manufacturers to present clear, unambiguous, and accurate information to the ...
YC-backed ReactWise is applying AI to speed up drug manufacturing
Artificial intelligence continues stirring things up in chemistry. To wit: Y Combinator-backed Cambridge, U.K.-based ...
How pharmaceutical companies are training their workers on AI
Seeking more efficient drug development, pharmaceutical giants and startups are encouraging AI fluency and in some cases ...
Sale of Ozempic Knockoffs Is Supposed to End Soon. Telehealth Companies Aren’t Happy.
Pharmaceutical giants are squaring off against telehealth companies and pharmacies selling custom-made versions of the hot ...
Bipartisan legislation focuses on prescription drug prices
Bipartisan legislation was reintroduced by Reps. Joe Courtney (D-CT) and Erin Houchin (R-IN), shining light on the prescription drug pricing system to provide fair deals to patients. The bill (320-71) ...